3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
27
Observational
2
Expanded_access
2
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
2
Leukemia, Plasma Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Bortezomib
20
Blood Specimen Collection
9
Surveys and Questionnaires
8
Lenalidomide
8
Dexamethasone
8
pomalidomide
6
daratumumab
6
Flow Cytometry
6
Immunoenzyme Techniques
5
Biopsy
5
plerixafor
4
idecabtagene vicleucel
4
carfilzomib
4
Standard of Care
4
Polymerase Chain Reaction
4
Amplified Fragment Length Polymorphism Analysis
4
Specimen Handling
3
Psychiatric Rehabilitation
3
Patient Reported Outcome Measures
3
Microarray Analysis
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Interviews as Topic
3
Drug Therapy
3
Data Collection
3
Cytogenetic Analysis
3
Chromatin Immunoprecipitation Sequencing
3
talquetamab
2
selinexor
2
belantamab mafodotin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
talquetamab
×
Plasma cell
×
Clear all
NCT06285318
2026-06-05
REALiTEC/TAL
Janssen-Cilag Ltd.
Recruiting
900 enrolled
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled